Skip to main content
Top
Published in: Lung 1/2011

01-02-2011

Hospitalization Rates and Survival Associated with COPD: A Nationwide Danish Cohort Study

Authors: Timothy L. Lash, Martin B. Johansen, Steffen Christensen, John A. Baron, Kenneth J. Rothman, Jens G. Hansen, Henrik Toft Sørensen

Published in: Lung | Issue 1/2011

Login to get access

Abstract

We examined rates of first hospitalization for COPD, rates of 5-year mortality among patients hospitalized for COPD, and comparisons of mortality between COPD patients and a matched cohort free of COPD. We computed standardized rates of first COPD hospitalization. Using Cox regression, we compared 180- and 181-day to 5-year mortality among COPD patients with the comparison cohort. We used medical databases in Denmark (population 5.4 million) from 1997 to 2006. We included patients 40 years or older with first hospitalization for COPD (64,499) and an age- and gender-matched comparison cohort of persons without COPD hospitalization (322,495). We examined the incidence of COPD hospitalization and risks and rates of mortality in the 5 years after hospitalization. Standardized rates of first hospitalization for COPD declined from 276 per 100,000 person-years in 1999 to 231 per 100,000 person-years in 2006. Within 180 days of hospitalization, 16% of COPD patients and 2.4% of persons in the matched cohort died (adjusted hazard ratio = 7.00, 95% CI = 6.79–7.22). Between 181 days and 5 years, 46% of COPD patients who survived the first 180 days and 19% of persons in the comparison cohort died (adjusted hazard ratio = 2.91, 95% CI = 2.86–2.95). COPD and comorbid diseases interacted to increase mortality in the first 180 days, but not thereafter. COPD continues to be a major public health problem causing substantial mortality in the 5 years after hospitalization, particularly in the first 180 days and in patients with comorbid diseases.
Literature
1.
go back to reference Rennard SI (1998) COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 113(4 Suppl):235S–241SCrossRefPubMed Rennard SI (1998) COPD: overview of definitions, epidemiology, and factors influencing its development. Chest 113(4 Suppl):235S–241SCrossRefPubMed
2.
go back to reference Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed Pauwels RA, Rabe KF (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed
3.
go back to reference Sethi JM, Rochester CL (2000) Smoking and chronic obstructive pulmonary disease. Clin Chest Med 21:67–86CrossRefPubMed Sethi JM, Rochester CL (2000) Smoking and chronic obstructive pulmonary disease. Clin Chest Med 21:67–86CrossRefPubMed
4.
go back to reference No author listed (2008) Deaths from chronic obstructive pulmonary disease—United States, 2000–2005. MMWR Morb Mortal Wkly Rep 57:1229–1232 No author listed (2008) Deaths from chronic obstructive pulmonary disease—United States, 2000–2005. MMWR Morb Mortal Wkly Rep 57:1229–1232
5.
go back to reference Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed
6.
go back to reference World Health Organization (2001) WHO Regional Office for Europe. The European report on tobacco control policy, Copenhagen World Health Organization (2001) WHO Regional Office for Europe. The European report on tobacco control policy, Copenhagen
7.
go back to reference Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646CrossRefPubMed Huiart L, Ernst P, Suissa S (2005) Cardiovascular morbidity and mortality in COPD. Chest 128:2640–2646CrossRefPubMed
8.
go back to reference McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748–1755CrossRefPubMed McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748–1755CrossRefPubMed
9.
go back to reference Fruchter O, Yigla M (2008) Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology 13:851–855CrossRefPubMed Fruchter O, Yigla M (2008) Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology 13:851–855CrossRefPubMed
10.
go back to reference Terzano C, Conti V, Di Sefano F, Petroianni A, Ceccarelli D, Graziani E, Mariotta S, Ricci A, Vitarelli A, Puglisi G, De Vito C, Villari P, Allegra L (2010) Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 188:321–329CrossRefPubMed Terzano C, Conti V, Di Sefano F, Petroianni A, Ceccarelli D, Graziani E, Mariotta S, Ricci A, Vitarelli A, Puglisi G, De Vito C, Villari P, Allegra L (2010) Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 188:321–329CrossRefPubMed
11.
go back to reference Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124:459–467CrossRefPubMed Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124:459–467CrossRefPubMed
12.
go back to reference Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C (2006) Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 7:109CrossRefPubMed Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C (2006) Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 7:109CrossRefPubMed
13.
go back to reference Holguin F, Folch E, Redd SC, Mannino DM (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128:2005–2011CrossRefPubMed Holguin F, Folch E, Redd SC, Mannino DM (2005) Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 128:2005–2011CrossRefPubMed
14.
go back to reference Nie JX, Wang L, Upshur RE (2007) Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J 14:485–489PubMed Nie JX, Wang L, Upshur RE (2007) Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. Can Respir J 14:485–489PubMed
15.
go back to reference Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959–967PubMed Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, Kussin P, Bellamy P, Goldman L, Knaus WA (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154:959–967PubMed
16.
go back to reference Geelhoed EA, Brameld KJ, Holman CD, Thompson PJ (2007) Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Int Med J 37:87–94CrossRef Geelhoed EA, Brameld KJ, Holman CD, Thompson PJ (2007) Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Int Med J 37:87–94CrossRef
17.
go back to reference Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM (2006) UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 61:837–842CrossRefPubMed Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM (2006) UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax 61:837–842CrossRefPubMed
18.
go back to reference Gershon AS, Wang C, Wilton AS, Raut R, To T (2010) Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007. Arch Int Med 170:560–565CrossRef Gershon AS, Wang C, Wilton AS, Raut R, To T (2010) Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007. Arch Int Med 170:560–565CrossRef
19.
go back to reference Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD (2005) COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128:2068–2075CrossRefPubMed Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD (2005) COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 128:2068–2075CrossRefPubMed
20.
21.
go back to reference Andersen TF, Madsen M, Jørgensen J, Mellemkjaer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed Andersen TF, Madsen M, Jørgensen J, Mellemkjaer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263–268PubMed
22.
go back to reference Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121:121S–126SCrossRefPubMed Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121:121S–126SCrossRefPubMed
23.
go back to reference Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370:1773–1779CrossRefPubMed Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370:1773–1779CrossRefPubMed
24.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMed
25.
go back to reference Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613–619CrossRefPubMed
26.
go back to reference Greenland S, Lash TL, Rothman KJ (2008) Concepts of interaction. In: Rothman KJ, Greenland S, Lash TL (eds) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 71–86 Greenland S, Lash TL, Rothman KJ (2008) Concepts of interaction. In: Rothman KJ, Greenland S, Lash TL (eds) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 71–86
28.
go back to reference Juel K, Døssing M (2003) KOL I Danmark. Sygdommen der hver dag koster 10 danskere livet. Statens Institut for Folkesundhed, København, ISBN 87-7899-063-7 Juel K, Døssing M (2003) KOL I Danmark. Sygdommen der hver dag koster 10 danskere livet. Statens Institut for Folkesundhed, København, ISBN 87-7899-063-7
29.
go back to reference Godtfredsen NS, Vestbo J, Osler M, Prescott E (2002) Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 57:967–972CrossRefPubMed Godtfredsen NS, Vestbo J, Osler M, Prescott E (2002) Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study. Thorax 57:967–972CrossRefPubMed
30.
go back to reference Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J (2006) Developing COPD: a 25 year follow-up study of the general population. Thorax 61:935–939CrossRefPubMed Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J (2006) Developing COPD: a 25 year follow-up study of the general population. Thorax 61:935–939CrossRefPubMed
31.
go back to reference Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165–1185CrossRefPubMed Barnes PJ, Celli BR (2009) Systemic manifestations and comorbidities of COPD. Eur Respir J 33:1165–1185CrossRefPubMed
33.
go back to reference Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56:124–130CrossRefPubMed Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M (2003) The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56:124–130CrossRefPubMed
34.
go back to reference Sørensen HT (1997) Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 10:1–22 Sørensen HT (1997) Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 10:1–22
35.
go back to reference Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C (2007) Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 101:1954–1960CrossRefPubMed Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C (2007) Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med 101:1954–1960CrossRefPubMed
36.
go back to reference Tabak C, Smit HA, Räsänen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Heederik D, Kromhout D (2001) Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. Epidemiology 12:239–245CrossRefPubMed Tabak C, Smit HA, Räsänen L, Fidanza F, Menotti A, Nissinen A, Feskens EJ, Heederik D, Kromhout D (2001) Alcohol consumption in relation to 20-year COPD mortality and pulmonary function in middle-aged men from three European countries. Epidemiology 12:239–245CrossRefPubMed
37.
go back to reference Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ (2009) Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study. Int J Chron Obstruct Pulmon Dis 4:137–148PubMed Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ (2009) Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III follow-up study. Int J Chron Obstruct Pulmon Dis 4:137–148PubMed
38.
go back to reference van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG (2009) Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 135:368–377CrossRefPubMed van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, Joos GF, Stricker BH, Brusselle GG (2009) Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam study. Chest 135:368–377CrossRefPubMed
39.
go back to reference Lindberg A, Eriksson B, Larsson LG, Ronmark E, Sandstrom T, Lundback B (2006) Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 129:879–885CrossRefPubMed Lindberg A, Eriksson B, Larsson LG, Ronmark E, Sandstrom T, Lundback B (2006) Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest 129:879–885CrossRefPubMed
40.
go back to reference de Marco, Accordini S, Cerveri I, Corsico A, Antó JM, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P, Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J, Leynaert B, Neukirch F, Schouten JP, Wjst M, Burney P (2007) Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 175:32–39CrossRefPubMed de Marco, Accordini S, Cerveri I, Corsico A, Antó JM, Künzli N, Janson C, Sunyer J, Jarvis D, Chinn S, Vermeire P, Svanes C, Ackermann-Liebrich U, Gislason T, Heinrich J, Leynaert B, Neukirch F, Schouten JP, Wjst M, Burney P (2007) Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 175:32–39CrossRefPubMed
41.
go back to reference Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL, Garau J (2002) Mortality after hospitalization for COPD. Chest 121:1441–1448CrossRefPubMed Almagro P, Calbo E, Ochoa de Echagüen A, Barreiro B, Quintana S, Heredia JL, Garau J (2002) Mortality after hospitalization for COPD. Chest 121:1441–1448CrossRefPubMed
42.
go back to reference Yohannes AM, Baldwin RC, Connolly MJ (2005) Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 34:491–496CrossRefPubMed Yohannes AM, Baldwin RC, Connolly MJ (2005) Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 34:491–496CrossRefPubMed
43.
go back to reference Abildstrom SZ, Rasmussen S, Madsen M (2005) Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 26:990–995CrossRefPubMed Abildstrom SZ, Rasmussen S, Madsen M (2005) Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed. Eur Heart J 26:990–995CrossRefPubMed
44.
go back to reference Iversen LH, Pedersen L, Riis A, Friis S, Laurberg S, Sørensen HT (2005) Population-based study of short- and long-term survival from colorectal cancer in Denmark 1977–1999. Br J Surg 92:873–880CrossRefPubMed Iversen LH, Pedersen L, Riis A, Friis S, Laurberg S, Sørensen HT (2005) Population-based study of short- and long-term survival from colorectal cancer in Denmark 1977–1999. Br J Surg 92:873–880CrossRefPubMed
Metadata
Title
Hospitalization Rates and Survival Associated with COPD: A Nationwide Danish Cohort Study
Authors
Timothy L. Lash
Martin B. Johansen
Steffen Christensen
John A. Baron
Kenneth J. Rothman
Jens G. Hansen
Henrik Toft Sørensen
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Lung / Issue 1/2011
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9274-z

Other articles of this Issue 1/2011

Lung 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.